The FDA has approved Hympavzi to prevent bleeding episodes in hemophilia A and B patients aged 12 and older. This innovative drug targets a blood protein rather than replacing clotting factors, showing superior efficacy in clinical trials.
A new “lumps and bumps” clinic provides faster, expert triage and treatment for children with painful, growing musculoskeletal tumors.
The Trump-Vance campaign is now going after The Washington Post.
The former president confirmed his plan to put Kennedy in a health care position if he wins reelection.
This is a Hybrid Course Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients…
Podcast Episode · INTERLUDE: Cancer Stories with Dr. Teplinsky · 11/01/2024 · 1 sec
NPR’s Mary Louise Kelly talks with Dr. Lucy McBride, doctor of internal medicine and podcast host, about managing election anxiety.
The OncoAlert Newsletter is now out for June 23-29, 2023
New research indicates that intravenous immunoglobulin (IVIG) therapy can reduce symptom severity for patients with gastroparesis.
